Unknown PHASE1 INTERVENTIONAL 2-arm NCT01659372

Low Level Laser Therapy Versus Pharmacotherapy in in Improving Masticatory Muscle Pain

Phase 1 Study of Low Level Laser Therapy Versus Naproxen

Sponsor: Shahid Beheshti University

Conditions TMD

Interventions Naproxen low level laser therapy

Updated 6 times since 2017 Last updated: Aug 6, 2012 Started: Jun 30, 2012 Primary completion: Dec 31, 2012 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates TMD and is currently ongoing. Shahid Beheshti University leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE1
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shahid Beheshti University

Data source: Shahid Beheshti University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tehran, Iran